Careers
Login
SUBSCRIBE TODAY
Careers
Login
SUBSCRIBE TODAY

Custom Market Research

Answer Your Top Market Access Questions

  • Launch Pricing and Contracting Strategy: Custom research that helps brands understand payer pricing expectations, contracting thresholds, and access requirements ahead of launch.
  • Impact of New Entrants: Primary payer and IDN research designed to evaluate how new competitors affect formulary placement, utilization management, and coverage decision‑making.
  • Loss of Exclusivity (LOE) Planning: Expert-led analysis to assess access risk, payer behavior, and generic or biosimilar uptake as brands plan for and navigate LOE.
  • Customizable, access-focused research design: MMIT combines our industry-leading panel with market access experts to answer brand‑specific access questions across the product lifecycle.
ACCESS THE BROCHURE

Understand How Payers Respond to Your Brand Messaging

What Our Clients Are Saying

"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."

Director, Commercial and Medical IT, Rare Disease

Global Biotech Company

"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."

Director, Commercial and Medical IT, Rare Disease

Global Biotech Company

"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."

Director, Commercial and Medical IT, Rare Disease

Global Biotech Company

"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."

Director, Commercial and Medical IT, Rare Disease

Global Biotech Company

How We Can Help

MMIT’s Custom Market Research delivers targeted market access insights when strategies matter most—at launch, during competitive disruption, and ahead of loss of exclusivity. By combining our industry-leading panel with market access experts, we help brands understand coverage decision‑making and act with confidence in a changing access landscape.

How can Custom Market Research help answer my most critical market access and commercial questions?

Custom Market Research delivers tailored insights aligned to your specific business challenges—such as pricing, coverage, competition, and lifecycle strategy—so you can address the questions that matter most to your brand.

How can Custom Market Research help uncover insights from payers and healthcare stakeholders?

Through primary qualitative and quantitative research MMIT uncovers real‑world perspectives on coverage decisions, access barriers, and treatment dynamics.

How can Custom Market Research help reduce uncertainty and improve decision-making?

By coupling our industry-leading panel with market access expertise, Custom Market Research provides decision‑ready intelligence that helps teams anticipate risk, validate strategies, and act with confidence.

RESOURCES

Key Insights From MMIT

Ebook

Improving Access with Market Research Insights

In this ebook, see how nine different manufacturers have partnered with MMIT on qualitative and quantitative custom market research.

ACCESS THE RESOURCE
ACCESS THE RESOURCE
Webinars

Strategies for Early Market Access Planning

This webinar explores how pharmaceutical companies are moving market access planning earlier into phases 1–3 to improve launch readiness, payer alignment, and long-term commercial performance. Speakers discuss how growing competition, pricing pressure, and regulatory changes are increasing the need for early, data-driven access strategy built on analog analysis, payer research, and integrated real-world data. The session also highlights how these insights help manufacturers refine value propositions, shape clinical development decisions, anticipate payer behavior, and strengthen commercialization strategy before launch.

What you’ll learn:

  • How historic analogs can help your team decide whether to pursue or license a product.
  • When early identification of payer priorities can lead to beneficial adjustments to your product’s value proposition.
  • What kind of data helps you anticipate (and circumvent) launch disadvantages.
ACCESS THE RESOURCE
ACCESS THE RESOURCE
Case Studies

Mobilizing Data for Product Launch Success

Learn how one small biopharma company achieved 95% payer coverage for its rare disease therapy using MMIT’s strategic data solutions.

ACCESS THE RESOURCE
ACCESS THE RESOURCE
RELATED SOLUTIONS

Solutions to Support Your Strategy

Enhance your custom research with related solutions, which offer swift access to payer and IDN decision-makers, timely and actionable feedback, and real-time visibility into treatment patterns, payer dynamics, and access trends. These benefits empower your team to move from insight to confident, informed action.

Rapid Response

Improve your brand strategy with Rapid Response’s quick, actionable answers to key business questions among a representative sample of the payer and IDN stakeholders that you care about.

Learn More
Stay In Touch

Be the first to know about new arrivals and promotions

Upcoming Webinar: Achieving Your Uptake Goals

REGISTER FOR ACCESS